Aspects of cell membrane function in adult polycystic kidney disease

Aspects of cell membrane function in adult polycystic kidney disease

Bibliographic Details
Main Author:	Vareesangthip, Kriengsak
Published:	University of Newcastle Upon Tyne 1997
Subjects:	572 Insulin resistance
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.361574

Similar Items

Kidney Transplantation Outcomes across Autosomal Dominant Polycystic Kidney Disease at Siriraj Hospital
by: Kriengsak Vareesangthip
Published: (2017-08-01)

Kidney Transplantation Outcomes across Autosomal Dominant Polycystic Kidney Disease at Siriraj Hospital
by: Kriengsak Vareesangthip, et al.
Published: (2017-07-01)

Metabolc aspects of polycystic ovary syndrome
by: Mojca Jensterle, et al.
Published: (2007-02-01)

Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic and Clinical Aspects
by: Federica Di Guardo, et al.
Published: (2020-07-01)

The Relationship between the Progression of Chronic Kidney Disease and Beta Cell Function in Non-Diabetic Korean Adults
by: Hyung Rag Kim
Published: (2020-09-01)

Optimization of ovarian function and metabolic status in syndrome of polycystic ovaries
by: Т. Ф Татарчук, et al.
Published: (2020-05-01)

Prevalence of chronic kidney disease in Thai adults: a national health survey
by: Khonputsa Panrasri, et al.
Published: (2009-10-01)

Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease
by: K Turkmen, et al.
Published: (2013-01-01)

Is serum amylase normal in women with polycystic ovarian syndrome?
by: Baghdad Science Journal
Published: (2014-12-01)

Polycystic Ovary Syndrome and the Relationship of Cardiovascular Disease Risk
by: Evrim Çakır, et al.
Published: (2013-06-01)

The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome
by: Nadia B. Pateguana, et al.
Published: (2019-07-01)

Polycystic ovary syndrome and periodontal disease: Underlying links- A review
by: Sri Chandana Tanguturi, et al.
Published: (2018-01-01)

The impact of serum visfatin, and resistin levels on insulin resistance in patients with polycystic ovary syndrome
by: Shatha Rouf Moustafa, et al.
Published: (2020-06-01)

High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
by: Tayebe Hemati, et al.
Published: (2011-01-01)

Polycystic Ovary Syndrome [Polikistik Over Sendromu]
by: Senem Arda Duz
Published: (2016-06-01)

Metabolic effects of polycystic ovary syndrome in adolescents
by: Yejin Han, et al.
Published: (2015-09-01)

Polycystic ovary syndrome: clinical implication in perimenopause
by: Monika Lenart-Lipińska, et al.
Published: (2014-12-01)

Cardiovascular system diseases in patients with polycystic ovary syndrome – the role of inflammation process in this pathology and possibility of early diagnosis and prevention
by: Aleksandra Marciniak, et al.
Published: (2016-09-01)

Oxidative Stress in Non-Obese Women with Polycystic Ovarian Syndrome
by: Varalakshmi Desai, et al.
Published: (2014-07-01)

The role of sterol regulatory element binding protein (SREBP)-Ic in glucose-regulated gene expression in pancreatic islet Î²-cells
by: Andreolas, Chrysovalantis
Published: (2002)

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights
by: Antonio Mancini, et al.
Published: (2021-02-01)

Association between Periodontal Diseases and Polycystic Ovary Syndrome: A Systematic Review
by: Cecilia Fabiana Márquez-Arrico, et al.
Published: (2020-05-01)

Frequency and correlates of comorbid depression in polycystic ovary syndrome
by: A B M Kamrul-Hasan, et al.
Published: (2020-06-01)

A review: Brief insight into Polycystic Ovarian syndrome
by: Jeshica Bulsara, et al.
Published: (2021-06-01)

A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS)
by: Maha H. Daghestani, et al.
Published: (2018-08-01)

Efficacy of 2-hour post glucose insulin levels in predicting insulin resistance in polycystic ovarian syndrome with infertility
by: Pikee Saxena, et al.
Published: (2011-01-01)

Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)
by: Anna Maria Fulghesu, et al.
Published: (2021-07-01)

Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome
by: Gourgari E, et al.
Published: (2016-08-01)

MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
by: O. V. Panarina, et al.
Published: (2017-07-01)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
by: Thozhukat Sathyapalan, et al.
Published: (2017-11-01)

Polycystic Ovary Syndrome Susceptibility Loci Inform Disease Etiological Heterogeneity
by: Yanfei Zhang, et al.
Published: (2021-06-01)

Serum Adiponectin Level and Clinical, Metabolic, and Hormonal Markers in Patients with Polycystic Ovary Syndrome
by: Yunus Yildiz, et al.
Published: (2014-01-01)

Polycystic ovary syndrome: approach to correction of metabolic disorders
by: Л. В. Калугіна, et al.
Published: (2020-05-01)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Assessment of Serum Vitamin D Levels in Women with Polycystic Ovary Syndrome
by: Rana A. Hamdi, et al.
Published: (2018-09-01)

Polycystic ovary syndrome: implications of metabolic dysfunction
by: Márcio Augusto Pinto de Ávila, et al.

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk
by: Srdan Pandurevic, et al.
Published: (2021-09-01)

THE ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME
by: I M Kutyrina, et al.
Published: (2012-06-01)

Correlation of Serum Lipoprotein Ratios with Insulin Resistance in Infertile Women with Polycystic Ovarian Syndrome: A Case Control Study
by: Aisa Ghaffarzad, et al.
Published: (2016-04-01)

Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study
by: Laura E. McBreairty, et al.
Published: (2019-07-01)